1 insider bought €386k of shares over the last 90 days, the latest filed 09 Oct 2026.
Every trade that managers of I.m.d. International Medical Devices disclose to Consob is tracked on this page. The company sits in the Health Care sector. From 18 October 2025 to 18 October 2026, the disclosure feed for I.m.d. International Medical Devices logged 3 filings by 1 insider.
No insider sold shares on the market over the period. Instead, the filings list 3 purchases totalling €386k, made by 1 insider. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Those buying include 1 senior executive. One trade stands out by size: a purchase of €129k, disclosed on 9 October 2026, or 0.57% of market capitalisation.
Compared with its exchange (224 companies, median 3 filings), a count of 3 filings is typical. Since 2023, the database holds 3 purchases and 1 sale by insiders of the company.
The latest purchase is recent: it was published 8 days ago, on 9 October 2026. Between a trade and the moment it shows up on Consob, the median delay is 1 day. The legal deadline for notifying a trade is three business days (MAR article 19).
In the same sector, recent insider purchases at Anixa Biosciences Inc and Vivos Inc also feature in our signals. This summary is built from Consob disclosures alone and does not predict where the share price will go.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
25 of 36 declarations
I.m.d. International Medical Devices is a company focused on the development and distribution of innovative medical devices. It operates in the XMIL market and aims to enhance healthcare through its products.
Purchases our model currently ranks for the recommendations list.
All recommendationsInsider filings
Over the last 90 days, 1 filing published on 9 October 2026: 1 open-market purchase by insiders for €129k.
Summary written automatically from public filings, without human review. General information, identical for every reader: it is not investment advice or a recommendation to buy or sell. Investing involves a risk of capital loss. Generated on 14 October 2026 (UTC)